{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:31:33Z","timestamp":1762324293443},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Health-related quality of life (HRQL) improved progressively during therapy and beyond in children treated for acute lymphoblastic leukemia on the Dana-Farber Cancer Institute (DFCI) 95-01 protocol. This study aimed to validate that trajectory in a successor study (DFCI 00-01) and to compare the HRQL of patients in the 2 studies. Children aged above 5 years were assessed during each phase of treatment (N=4) and 2 years after completion of therapy. Health status and HRQL were measured using Health Utilities Index (HUI) instruments, HUI2 and HUI3. Quality-adjusted life years (QALYs) were calculated and compared with the general population, and patients treated on DFCI 95-01. Over 5 intervals and 758 HUI assessments, mean HRQL increased progressively from remission induction to the time after treatment (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). During intensification, high-risk patients had lower HRQL than standard-risk patients (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). During remission induction, patients on DFCI 95-01 had lower HRQL than patients on DFCI 00-01. Patients on DFCI 00-01 had ~0.2 and 0.3 fewer QALYs than controls, measured by HUI2 and HUI3, respectively. QALYs for DFCI 00-01 patients during treatment were similar to those for DFCI 95-01 patients. The trajectory of improvement in HRQL during the treatment of acute lymphoblastic leukemia in children was confirmed.<\/jats:p>","DOI":"10.1097\/mph.0000000000001235","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T15:11:30Z","timestamp":1528816290000},"page":"580-587","source":"Crossref","is-referenced-by-count":6,"title":["Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol"],"prefix":"10.1097","volume":"40","author":[{"given":"Charlene","family":"Rae","sequence":"first","affiliation":[{"name":"Centre for Health Economics and Policy Analysis"},{"name":"Health Research Methods, Evidence, and Impact"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Furlong","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Policy Analysis"},{"name":"Health Utilities Inc., Dundas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feeny","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Policy Analysis"},{"name":"Economics"},{"name":"Health Utilities Inc., Dundas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Couchman","sequence":"additional","affiliation":[{"name":"Nursing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis","family":"Silverman","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, and Boston Children\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sallan","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, and Boston Children\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Laverdiere","sequence":"additional","affiliation":[{"name":"H\u00f4pital Sainte Justine, Montreal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Clavell","sequence":"additional","affiliation":[{"name":"San Jorge Children\u2019s Hospital, San Juan, Puerto Rico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Michon","sequence":"additional","affiliation":[{"name":"Le Centre Hospitalier de l\u2019Universite Laval, Quebec City, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Kelly","sequence":"additional","affiliation":[{"name":"Columbia Presbyterian Medical Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Larsen","sequence":"additional","affiliation":[{"name":"Maine Children\u2019s Cancer Program, Scarborough, ME"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Pullenayegum","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Athale","sequence":"additional","affiliation":[{"name":"Pediatrics, McMaster University"},{"name":"McMaster Children\u2019s Hospital, Hamilton"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Barr","sequence":"additional","affiliation":[{"name":"Pediatrics, McMaster University"},{"name":"McMaster Children\u2019s Hospital, Hamilton"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2014.142","article-title":"A revised definition for cure of childhood acute lymphoblastic leukemia","volume":"28","author":"Pui","year":"2014","journal-title":"Leukemia"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pbc.24096","article-title":"Health-related quality of life among children with acute lymphoblastic leukemia","volume":"59","author":"Furlong","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.29708","article-title":"Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: results of Children\u2019s Oncology Group study AALL 0331","volume":"138","author":"Mitchell","year":"2016","journal-title":"Int J Cancer"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"e26489","DOI":"10.1002\/pbc.26489","article-title":"Health-related quality of life of children on treatment for acute lymphoblastic leukemia: a systematic review","volume":"64","author":"Fardell","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/leu.2009.253","article-title":"Long-term results of Dana-Farber Cancer Institute ALL consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)","volume":"24","author":"Silverman","year":"2010","journal-title":"Leukemia"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","article-title":"Postinduction dexamethasone and individualized dosing of Escherichia coli l-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study. Dana-Farber Cancer Institute ALL Consortium Protocol 00-01","volume":"31","author":"Vrooman","year":"2013","journal-title":"J Clin Oncol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2006-06-027714","article-title":"Results of the Dana Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia","volume":"109","author":"Moghrabi","year":"2007","journal-title":"Blood"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The Health Utilities Index (HUI): concepts, measurement properties and applications","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890109002092","article-title":"The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies","volume":"33","author":"Furlong","year":"2001","journal-title":"Ann Med"},{"key":"R11-20230918","first-page":"43","article-title":"Validation of disability categories derived from Health Utilities Index Mark 3 scores","volume":"20","author":"Feng","year":"2009","journal-title":"Health Rep"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1542\/peds.105.3.569","article-title":"Parental perspectives of the health status and health-related quality of life of teen-aged children who were extremely low birth weight and term controls","volume":"105","author":"Saigal","year":"2000","journal-title":"Pediatrics"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11136-005-0198-7","article-title":"Health status in survivors of cancer in childhood and adolescence","volume":"15","author":"Pogany","year":"2006","journal-title":"Qual Life Res"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jncimonographs\/lgh002","article-title":"A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia","volume":"33","author":"Pickard","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/pbc.21456","article-title":"Economic evaluation and health-related quality of life","volume":"50","author":"Calaminus","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/ijc.25433","article-title":"Quality of life during active treatment for pediatric acute lymphoblastic leukemia","volume":"128","author":"Sung","year":"2011","journal-title":"Int J Cancer"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood-2015-01-621680","article-title":"Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia","volume":"125","author":"Ness","year":"2015","journal-title":"Blood"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/cncr.10428","article-title":"The PedsQL in pediatric cancer; reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale and Cancer Module","volume":"94","author":"Varni","year":"2002","journal-title":"Cancer"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0029-1216366","article-title":"Health-related quality of life (HRQL) in ALL-patients treated with chemotherapy only\u2014a report from the late effects surveillance system in Germany","volume":"221","author":"Peeters","year":"2009","journal-title":"Klin Padiatr"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11136-012-0183-x","article-title":"Health-related quality of life and utility scores in short-term survivors of pediatric acute lymphoblastic leukemia","volume":"22","author":"Van Litsenburg","year":"2013","journal-title":"Qual Life Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201811000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:09:58Z","timestamp":1695010198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201811000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001235","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}